Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1132)
PALVELLA THERAPEUTICS, INC. (PVLA)
Goin Kathleen — Chief Operating Officer
Shares
1,887
Price
$111.31
Total Value
$210.05K
Shares Held After
25
% of Holdings
98.7%
PALVELLA THERAPEUTICS, INC. (PVLA)
Goin Kathleen — Chief Operating Officer
Shares
2,390
Price
$110.26
Total Value
$263.52K
Shares Held After
1,912
% of Holdings
55.6%
Dyne Therapeutics, Inc. (DYN)
Kersten Dirk — Director
Shares
37,454
Price
$20.14
Total Value
$754.32K
Shares Held After
4,159,119
% of Holdings
0.9%
Pasithea Therapeutics Corp. (KTTA)
Coastlands Capital LP — 10% Owner
Shares
100,000
Price
$0.53
Total Value
$53.00K
Shares Held After
3,835,035
% of Holdings
2.6%
uniQure N.V. (QURE)
Balachandran Madhavan — Director
Shares
1,690
Price
$42.60
Total Value
$71.99K
Shares Held After
43,254
% of Holdings
3.8%
uniQure N.V. (QURE)
Balachandran Madhavan — Director
Shares
4,700
Price
$43.66
Total Value
$205.20K
Shares Held After
44,944
% of Holdings
9.5%
uniQure N.V. (QURE)
Balachandran Madhavan — Director
Shares
5,295
Price
$47.08
Total Value
$249.29K
Shares Held After
49,644
% of Holdings
9.6%
uniQure N.V. (QURE)
Kaye Jack — Director
Shares
5,295
Price
$42.57
Total Value
$225.41K
Shares Held After
25,996
% of Holdings
16.9%
uniQure N.V. (QURE)
Kapusta Matthew C — Director
Shares
11,585
Price
$48.65
Total Value
$563.61K
Shares Held After
558,810
% of Holdings
2.0%
uniQure N.V. (QURE)
Kapusta Matthew C — Director
Shares
33,334
Price
$45.01
Total Value
$1.50M
Shares Held After
570,395
% of Holdings
5.5%
uniQure N.V. (QURE)
Kapusta Matthew C — Director
Shares
56,929
Price
$43.43
Total Value
$2.47M
Shares Held After
603,729
% of Holdings
8.6%
uniQure N.V. (QURE)
Kapusta Matthew C — Director
Shares
32,581
Price
$45.02
Total Value
$1.47M
Shares Held After
660,658
% of Holdings
4.7%
uniQure N.V. (QURE)
Kapusta Matthew C — Director
Shares
6,023
Price
$43.70
Total Value
$263.21K
Shares Held After
693,239
% of Holdings
0.9%
uniQure N.V. (QURE)
Kapusta Matthew C — Director
Shares
23,977
Price
$42.61
Total Value
$1.02M
Shares Held After
699,262
% of Holdings
3.3%
Nasus Pharma Ltd (NSRX)
Teleman Dan Benjamin — Director
Shares
6,550
Price
$3.10
Total Value
$20.30K
Shares Held After
163,541
% of Holdings
4.0%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
1,500
Price
$0.85
Total Value
$1.27K
Shares Held After
299,766
% of Holdings
0.5%
NEKTAR THERAPEUTICS (NKTR)
ROBIN HOWARD W — Director
Shares
4,500
Price
$61.65
Total Value
$277.43K
Shares Held After
55,045
% of Holdings
7.6%
NEKTAR THERAPEUTICS (NKTR)
ROBIN HOWARD W — Director
Shares
5,500
Price
$60.81
Total Value
$334.45K
Shares Held After
59,545
% of Holdings
8.5%
Mirum Pharmaceuticals, Inc. (MIRM)
Howe Jolanda — SVP, GLOBAL CONTROLLER
Shares
2,594
Price
$101.95
Total Value
$264.46K
Shares Held After
5,835
% of Holdings
30.8%
Cadrenal Therapeutics, Inc. (CVKD)
Pham Quang X — Director
Shares
513
Price
$3.16
Total Value
$1.62K
Shares Held After
128,589
% of Holdings
0.4%
Crinetics Pharmaceuticals, Inc. (CRNX)
Okey Stephanie — Director
Shares
608
Price
$36.22
Total Value
$22.02K
Shares Held After
6,400
% of Holdings
8.7%
Crinetics Pharmaceuticals, Inc. (CRNX)
Okey Stephanie — Director
Shares
6,292
Price
$35.62
Total Value
$224.12K
Shares Held After
7,008
% of Holdings
47.3%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Veness Adam M — SVP, General Counsel and Sec.
Shares
13,229
Price
$81.38
Total Value
$1.08M
Shares Held After
0
% of Holdings
100.0%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Veness Adam M — SVP, General Counsel and Sec.
Shares
16,771
Price
$80.34
Total Value
$1.35M
Shares Held After
13,229
% of Holdings
55.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
574
Price
$555.63
Total Value
$318.93K
Shares Held After
40,513
% of Holdings
1.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,909
Price
$554.77
Total Value
$1.06M
Shares Held After
41,087
% of Holdings
4.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,201
Price
$553.78
Total Value
$665.09K
Shares Held After
42,996
% of Holdings
2.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
727
Price
$552.75
Total Value
$401.85K
Shares Held After
44,197
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,840
Price
$551.73
Total Value
$1.02M
Shares Held After
44,924
% of Holdings
3.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,077
Price
$550.87
Total Value
$1.14M
Shares Held After
46,764
% of Holdings
4.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
612
Price
$549.57
Total Value
$336.34K
Shares Held After
48,841
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
560
Price
$548.57
Total Value
$307.20K
Shares Held After
49,453
% of Holdings
1.1%
CORCEPT THERAPEUTICS INC (CORT)
MAHONEY DAVID L — Director
Shares
20,000
Price
$84.53
Total Value
$1.69M
Shares Held After
26,147
% of Holdings
43.3%
ASSEMBLY BIOSCIENCES, INC. (ASMB)
Bjorkquist Jeanette M — PFO and PAO
Shares
29
Price
$23.25
Total Value
$674.25
Shares Held After
14,560
% of Holdings
0.2%
Monte Rosa Therapeutics, Inc. (GLUE)
Townson Sharon — Chief Scientific Officer
Shares
3,000
Price
$19.00
Total Value
$57.00K
Shares Held After
67,845
% of Holdings
4.2%
Monte Rosa Therapeutics, Inc. (GLUE)
Champoux Jennifer — Chief Operating Officer
Shares
2,176
Price
$19.00
Total Value
$41.34K
Shares Held After
62,371
% of Holdings
3.4%
ARVINAS, INC. (ARVN)
Cacace Angela M — Chief Scientific Officer
Shares
2,576
Price
$7.59
Total Value
$19.56K
Shares Held After
180,390
% of Holdings
1.4%
Aditxt, Inc. (ADTX)
DRW Securities, LLC — 10% Owner
Shares
126,772
Price
$0.01
Total Value
$1.00K
Shares Held After
0
% of Holdings
100.0%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
4,584
Price
$25.00
Total Value
$114.60K
Shares Held After
57,095
% of Holdings
7.4%
Mineralys Therapeutics, Inc. (MLYS)
Karydas Daphne — Director
Shares
3,000
Price
$25.00
Total Value
$75.00K
Shares Held After
6,200
% of Holdings
32.6%
Arcutis Biotherapeutics, Inc. (ARQT)
Welgus Howard G. — Director
Shares
635
Price
$25.67
Total Value
$16.30K
Shares Held After
37,743
% of Holdings
1.7%
Revolution Medicines, Inc. (RVMD)
Horn Margaret A — Chief Operating Officer
Shares
29,600
Price
$160.12
Total Value
$4.74M
Shares Held After
154,647
% of Holdings
16.1%
Oncotelic Therapeutics, Inc. (OTLC)
Trieu Vuong — Director
Shares
239,759
Price
$0.04
Total Value
$10.69K
Shares Held After
93,629,319
% of Holdings
0.3%
Acumen Pharmaceuticals, Inc. (ABOS)
Porter Derrell — Director
Shares
13,040
Price
$2.33
Total Value
$30.32K
Shares Held After
35,500
% of Holdings
26.9%
Eton Pharmaceuticals, Inc. (ETON)
Adams Jennifer McKie — Director
Shares
50,000
Price
$32.48
Total Value
$1.62M
Shares Held After
0
% of Holdings
100.0%
NEKTAR THERAPEUTICS (NKTR)
ROBIN HOWARD W — Director
Shares
4,697
Price
$60.71
Total Value
$285.15K
Shares Held After
65,045
% of Holdings
6.7%
NEKTAR THERAPEUTICS (NKTR)
ROBIN HOWARD W — Director
Shares
5,303
Price
$59.97
Total Value
$318.02K
Shares Held After
69,742
% of Holdings
7.1%
Cadrenal Therapeutics, Inc. (CVKD)
Pham Quang X — Director
Shares
3,613
Price
$3.18
Total Value
$11.49K
Shares Held After
129,102
% of Holdings
2.7%
Revolution Medicines, Inc. (RVMD)
Kelsey Stephen Michael — President, Research and Development
Shares
4,175
Price
$156.12
Total Value
$651.80K
Shares Held After
291,876
% of Holdings
1.4%
Revolution Medicines, Inc. (RVMD)
Cislini Jeff — General Counsel
Shares
2,157
Price
$156.12
Total Value
$336.75K
Shares Held After
56,521
% of Holdings
3.7%
Showing 1–50 of 1132 transactions (page 1 of 23)